Citigroup Inc Abbott Laboratories Put Options Transaction History

Citigroup Inc

13 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2024 Nov 12, 2024	BUY	$100.07 - $118.13 $7.08 Million - $8.36 Million	70,800 Added 25.13%	352,500 $40.2 Million
Q2 2024 Aug 12, 2024	SELL	$100.73 - $112.44 $13.6 Million - $15.2 Million	-135,200 Reduced 32.43%	281,700 $29.3 Million
Q1 2024 May 10, 2024	SELL	$109.52 - $120.96 $8.32 Million - $9.19 Million	-76,000 Reduced 15.42%	416,900 $47.4 Million
Q4 2023 Feb 09, 2024	BUY	$90.19 - $110.4 $5.36 Million - $6.56 Million	59,400 Added 13.7%	492,900 $54.3 Million
Q3 2023 Nov 09, 2023	BUY	$95.53 - $114.62 $6.6 Million - $7.92 Million	69,100 Added 18.96%	433,500 $42 Million
Q2 2023 Aug 10, 2023	BUY	$100.78 - $112.29 $13.4 Million - $15 Million	133,400 Added 57.75%	364,400 $39.7 Million
Q1 2023 May 11, 2023	SELL	$96.86 - $114.01 $80.4 Million - $94.6 Million	-829,900 Reduced 78.23%	231,000 $23.4 Million
Q4 2022 Feb 09, 2023	BUY	$95.06 - $111.52 $7.63 Million - $8.96 Million	80,300 Added 8.19%	1,060,900 $116 Million
Q3 2022 Nov 10, 2022	BUY	$96.76 - $112.03 $34.6 Million - $40.1 Million	357,600 Added 57.4%	980,600 $94.9 Million
Q2 2022 Aug 10, 2022	BUY	$102.07 - $123.37 $49.7 Million - $60.1 Million	487,000 Added 358.09%	623,000 $67.7 Million
Q1 2022 May 12, 2022	SELL	$114.02 - $139.04 $40.7 Million - $49.6 Million	-356,600 Reduced 72.39%	136,000 $16.1 Million
Q4 2021 Feb 10, 2022	SELL	$115.53 - $141.46 $3.86 Million - $4.72 Million	-33,400 Reduced 6.35%	492,600 $69.3 Million
Q3 2021 Nov 10, 2021	BUY	$116.66 - $129.06 $61.4 Million - $67.9 Million	526,000 New	526,000 $62.1 Million

3,186

1.3B

8.74M

8.08M

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $206B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

Get notified when there are updates to the investment portfolio of Citigroup Inc, based on Form 13F filings with the SEC.

Stay updated on Citigroup Inc with notifications on news.